Galen Partners is a leading healthcare growth equity, late stage, venture capital firm that focuses on investments in healthcare technology-enabled services, medical devices and specialty pharmaceutical companies.
Galen has invested in more than 70 companies since 1990 and has nearly $1 billion in assets under management. The firm leads investments of $10 million to $30 million of growth equity capital.
Galen continues its tradition of strategic collaboration and active partnership with its portfolio company management teams to build healthcare market leaders.
Seventure Partners (Paris, France) is a healthcare and nutrition specialist fund manager, investing out of its latest Health For Life Capital™ vehicle. With over €600m in assets under management Seventure is an active player in the fields of healthcare and digital technologies. Since 1997 Seventure has invested in innovative businesses from early to growth stages, across Europe and North America.
In life sciences, the core areas of focus are microbiome, nutrition, consumer health and digital health, food tech and personalized medicine. The investment team shares with the portfolio companies an in-depth expertise and unparalleled industry network in the areas of investment focus as well as passion for bringing cutting edge innovations to market. In December 2015, Seventure Partners successfully held the final closing of its Health for Life Capital™ vehicle, attracting both financial institutional and private investors and a broad range of industry limited partners, representing a variety of sectors, from food, clinical nutrition, ingredients to consumer healthcare and pharma.
Seventure is part of Natixis Global Asset Management group. Natixis is the corporate investment management and financial services arm of Groupe BPCE, the second-largest French bank.
For more details: www.seventure.com